Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 8Terminated 4Completed 4Active not recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 34Leukemia, Lymphocytic, Chronic, B-Cell 26Myelodysplastic Syndromes 10Lymphoma, Mantle-Cell 8Neoplasms 7Leukemia, Myelomonocytic, Chronic 7Burkitt Lymphoma 7Recurrence 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma, B-Cell 5Myeloproliferative Disorders 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Biphenotypic, Acute 4Leukemia, B-Cell 4Waldenstrom Macroglobulinemia 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia 3Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Hematologic Neoplasms 2Hematologic Diseases 2Thrombocytosis 1Thrombocythemia, Essential 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1

Interventions

fludarabine 6trametinib 5Specimen Handling 5Standard of Care 4Practice Guidelines as Topic 4Magnetic Resonance Spectroscopy 4fludarabine phosphate 3Whole-Body Irradiation 3Mycophenolic Acid 3Melphalan 3Interviews as Topic 3GSK2636771 3Cyclophosphamide 3Crizotinib 3Busulfan 3Biopsy 3Antilymphocyte Serum 3AP 1903 reagent 3venetoclax 2thymoglobulin 2palbociclib 2osimertinib 2letermovir 2dabrafenib 2capivasertib 2binimetinib 2adavosertib 2X-Rays 2Thiotepa 2Tacrolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Hematologic Neoplasms × venetoclax × Clear all
NCT05753501 2026-06-02

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

AbbVie

Phase 1 Active not recruiting
135 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT05428969 2026-04-23

BEXMAB

Faron Pharmaceuticals Ltd

Phase 1/2 Active not recruiting
181 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡